AMS Plans PMA Supplement After TherMatrx Claims Draw FDA Scrutiny
This article was originally published in The Gray Sheet
Executive Summary
American Medical Systems says it is preparing a PMA supplement that will include five-year follow-up data for the TherMatrx TMx-2000 BPH thermotherapy system
You may also be interested in...
People In Brief
American Medical Systems: Martin Emerson assumes Minnetonka, Minn. firm's president & CEO spot effective Jan. 5, replacing Douglas Kohrs, who will remain chairman of AMS' board. A 20-year device industry veteran, Emerson has spent his last four years at American Medical Systems in various executive roles, including VP-general manager of international, exec VP-global sales & marketing and chief operating officer. His previous career experience includes stints at Baxter International and Boston Scientific. Currently, AMS is preparing a PMA supplement for its TherMatrx TMx-2000 BPH thermotherapy system (1"The Gray Sheet" Nov. 8, 2004, p. 6)...
People In Brief
American Medical Systems: Martin Emerson assumes Minnetonka, Minn. firm's president & CEO spot effective Jan. 5, replacing Douglas Kohrs, who will remain chairman of AMS' board. A 20-year device industry veteran, Emerson has spent his last four years at American Medical Systems in various executive roles, including VP-general manager of international, exec VP-global sales & marketing and chief operating officer. His previous career experience includes stints at Baxter International and Boston Scientific. Currently, AMS is preparing a PMA supplement for its TherMatrx TMx-2000 BPH thermotherapy system (1"The Gray Sheet" Nov. 8, 2004, p. 6)...
TherMatrx Purchase Gives American Medical Systems In-Office BPH Presence
American Medical Systems expects the physician office market for benign prostate hyperplasia treatment to continue to grow by greater than 30% following its acquisition of in-office microwave BPH firm TherMatrx